Form D · Biotechnology
UNIGENE LABORATORIES INC
Boonton, NJ · CIK 0000352747
Offering snapshot reported Apr 22, 2013 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2013 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Oct 9, 2012 | Initial | $4,000,000 | No comparison | 4 | SEC filing |
| Mar 29, 2010 | Initial | $33,000,000 | No comparison | 1 | SEC filing |
| Oct 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195335
Issuance of senior secured convertible notes convertible into shares of Unigene's common stock under certain circumstances. Full conversion is subject to Unigene amending its charter to increase the number of shares which Unigene is authorized to issue.
Source: Form D, filed Apr 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Thomas August | Director |
| Allen Bloom | Director |
| Zvi Eiref | Director |
| James P. Gilligan | Executive |
| Ronald S. Levy | Executive |
| Richard Levy | Director |
| Gregory Mayes | Director, Executive |
| Nozer M. Mehta | Executive |
| Marvin Miller | Director |
| Bruce Morra | Director |
| Theron Odlaug | Director |
| Ashleigh Palmer | Director, Executive |
| Thomas Sabatino, Jr. | Director |
| Paul P. Shields | Executive |
| Peter Slusser | Director |
| William Steinhauer | Executive |
| Roxanne Tavakkol | Executive |
| Joel Tune | Director |
| Jack Wyszomierski | Director |
| Brian Zietsman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
81 Fulton Street
Boonton, NJ, 07005
Boonton, NJ, 07005